STAT3 and glioblastoma: It should be noted that these findings are somewhat contradicted by recent work from Heynckes et al. [135], which found that recurrent GBM tissue from Stupp regimen-treated patients demonstrated decreased phospho-STAT3 expression compared to their original tumors.